There is increasing evidence that the induction of inflammation and production of inflammatory mediators released from the adipose tissue of obese subjects, such as adipocytokines and classical cytokines contribute to obesity-induced NAFLD, in which IL-1α/β plays a key role (Figure 4) (95, 96). Here, IL1A is linked to metabolic dysfunction-associated steatotic liver disease.